Brisson L, Banski P, Sboarina M, Dethier C, Danhier P, Fontenille MJ, et al. Lactate dehydrogenase B controls lysosome activity and autophagy in cancer. Cancer Cell. 2016;30:418–31. https://doi.org/10.1016/j.ccell.2016.08.005.
Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9. https://doi.org/10.1038/nature13480
Chen Z, Fan J, Chen X, Yang K, Wang K. Oxidative stress and redox signaling in gastric cancer: from mechanisms to therapeutic implications. Antioxidants. 2025. https://doi.org/10.3390/antiox14030258.
Deng H, Zhao L, Ge H, Gao Y, Fu Y, Lin Y, et al. Ubiquinol-mediated suppression of mitochondria-associated ferroptosis is a targetable function of lactate dehydrogenase B in cancer. Nat Commun. 2025;16:2597. https://doi.org/10.1038/s41467-025-57906-3.
Dong Z, Yuan Z, Jin T, Gao C, Wang X, Xu F. Lactate at the crossroads of tumor metabolism and immune escape: a new frontier in cancer therapy. J Transl Med. 2025;23:1239. https://doi.org/10.1186/s12967-025-07272-x.
Frank AC, Raue R, Fuhrmann DC, Sirait-Fischer E, Reuse C, Weigert A, et al. Lactate dehydrogenase B regulates macrophage metabolism in the tumor microenvironment. Theranostics. 2021;11:7570–88. https://doi.org/10.7150/thno.58380.
Ge H, Malsiu F, Gao Y, Losmanova T, Blank F, Ott J, et al. Inhibition of LDHB suppresses the metastatic potential of lung cancer by reducing mitochondrial GSH catabolism. Cancer Lett. 2024;611:217353. https://doi.org/10.1016/j.canlet.2024.217353.
Gyorffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation (Camb). 2024;5:100625. https://doi.org/10.1016/j.xinn.2024.100625.
He Y, Song T, Ning J, Wang Z, Yin Z, Jiang P, et al. Lactylation in cancer: mechanisms in tumour biology and therapeutic potentials. Clin Transl Med. 2024;14:e70070. https://doi.org/10.1002/ctm2.70070.
Hong W, Zeng X, Wang H, Tan X, Tian Y, Hu H, et al. PGC-1α loss promotes mitochondrial protein lactylation in acetaminophen-induced liver injury via the LDHB-lactate axis. Pharmacol Res. 2024;205:107228. https://doi.org/10.1016/j.phrs.2024.107228.
Hu XT, Wu XF, Xu JY, Xu X. Lactate-mediated lactylation in human health and diseases: Progress and remaining challenges. J Adv Res. 2024b. https://doi.org/10.1016/j.jare.2024.11.010.
Hu X, Huang Z, Li L. LDHB Mediates Histone Lactylation to Activate PD-L1 and Promote Ovarian Cancer Immune Escape. Cancer Invest. 2024a:1-10https://doi.org/10.1080/07357907.2024.2430283
Leong T, Smithers BM, Michael M, Haustermans K, Wong R, Gebski V, et al. Preoperative chemoradiotherapy for resectable gastric cancer. N Engl J Med. 2024;391:1810–21. https://doi.org/10.1056/NEJMoa2405195.
Li Y, Liu J, Wu S, Xiao J, Zhang Z. Ferroptosis: opening up potential targets for gastric cancer treatment. Mol Cell Biochem. 2024;479:2863–74. https://doi.org/10.1007/s11010-023-04886-x.
Lin XM, Li S, Zhou C, Li RZ, Wang H, Luo W, et al. Cisplatin induces chemoresistance through the PTGS2-mediated anti-apoptosis in gastric cancer. Int J Biochem Cell Biol. 2019;116:105610. https://doi.org/10.1016/j.biocel.2019.105610.
Liu W, Chakraborty B, Safi R, Kazmin D, Chang CY, McDonnell DP. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat Commun. 2021;12:5103. https://doi.org/10.1038/s41467-021-25354-4.
Liu X, Zhuang L, Gan B. Disulfidptosis: disulfide stress-induced cell death. Trends Cell Biol. 2024;34:327–37. https://doi.org/10.1016/j.tcb.2023.07.009.
Lv M, Huang Y, Chen Y, Ding K. Lactylation modification in cancer: mechanisms, functions, and therapeutic strategies. Exp Hematol Oncol. 2025;14:32. https://doi.org/10.1186/s40164-025-00622-x.
Ni X, Lu CP, Xu GQ, Ma JJ. Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy. Acta Pharmacol Sin. 2024;45:1533–55. https://doi.org/10.1038/s41401-024-01264-1.
Pouyssegur J, Marchiq I, Parks SK, Durivault J, Zdralevic M, Vucetic M. Warburg effect’ controls tumor growth, bacterial, viral infections and immunity - genetic deconstruction and therapeutic perspectives. Semin Cancer Biol. 2022;86:334–46. https://doi.org/10.1016/j.semcancer.2022.07.004.
Shukri AH, Lukinovic V, Charih F, Biggar KK. Unraveling the battle for lysine: a review of the competition among post-translational modifications. Biochim Biophys Acta Gene Regul Mech. 2023;1866:194990. https://doi.org/10.1016/j.bbagrm.2023.194990.
Sui Y, Shen Z, Wang Z, Feng J, Zhou G. Lactylation in cancer: metabolic mechanism and therapeutic strategies. Cell Death Discov. 2025;11:68. https://doi.org/10.1038/s41420-025-02349-4.
Wan J, Shi JH, Shi M, Huang H, Zhang Z, Li W, et al. Lactate dehydrogenase B facilitates disulfidptosis and exhaustion of tumour-infiltrating CD8(+) T cells. Nat Cell Biol. 2025;27:972–82. https://doi.org/10.1038/s41556-025-01673-2.
Wang W, Green M, Choi JE, Gijon M, Kennedy PD, Johnson JK, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569:270–4. https://doi.org/10.1038/s41586-019-1170-y.
Wu Z, Huang R, Yuan L. Crosstalk of intracellular post-translational modifications in cancer. Arch Biochem Biophys. 2019;676:108138. https://doi.org/10.1016/j.abb.2019.108138.
Yang Z, Zou S, Zhang Y, Zhang J, Zhang P, Xiao L, et al. ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis. Nat Commun. 2023;14:4193. https://doi.org/10.1038/s41467-023-39901-8.
Zdralevic M, Brand A, Di Ianni L, Dettmer K, Reinders J, Singer K, et al. Double genetic disruption of lactate dehydrogenases A and B is required to ablate the “Warburg effect” restricting tumor growth to oxidative metabolism. J Biol Chem. 2018;293:15947–61. https://doi.org/10.1074/jbc.RA118.004180.
Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575–80. https://doi.org/10.1038/s41586-019-1678-1.
Zhao L, Deng H, Zhang J, Zamboni N, Yang H, Gao Y, et al. Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer. Cell Death Differ. 2025;32:632–45. https://doi.org/10.1038/s41418-024-01427-x.
Zheng Y, Sun L, Guo J, Ma J. The crosstalk between ferroptosis and anti-tumor immunity in the tumor microenvironment: molecular mechanisms and therapeutic controversy. Cancer Commun. 2023;43:1071–96. https://doi.org/10.1002/cac2.12487.
Comments (0)